Clinical Trial Update: Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1, multiple-dose study of PF-04991532 in patients with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-04991532 (PF-04991532)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED